Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01954706 · ClinicalTrials.gov registry record · NA
Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
A NA study, sponsored by Baltimore VA Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01954706: Clinical Trial NA study, sponsored by Baltimore VA Medical Center.
NCT01954706 is a NA study that was terminated before completion, run by Baltimore VA Medical Center. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01954706, a NA study, was terminated before completion, sponsored by Baltimore VA Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Hormone receptor-positive tumors are the most common breast cancers in postmenopausal women, and drug therapies, which block the production or effects of estrogen, are the mainstay of treatment in these patients. Due to their effectiveness in postmenopausal women, aromatase inhibitors (AIs) are the standard of care for long-term estrogen suppression in these patients. Estrogen deficiency, however, results in multiple side effects. Some of the most common side effects in women taking AIs are joint and muscle aches, which promote physical deconditioning. Because of the long term use of AIs in postmenopausal breast cancer patients and the improvements in cancer-related outcomes that are observed with their use, identifying methods to reduce these side effects to maintain adherence to treatment is important. Exercise interventions in breast cancer patients also improve quality of life and reduce fatigue. Understanding the role of exercise in AI side effect prevention will allow us to translate these findings into therapy guidelines.
Primary Outcome
Fatigue (questionnaires) and muscle performance (muscle strength, endurance, and function)
Interventions
- OTHER Usual Care
- OTHER Structured Exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-09 |
| Phase | NA |
Why NCT01954706 stopped before completion
NCT01954706 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT01954706 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01954706 about?
NCT01954706 is a clinical study titled "Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients". Hormone receptor-positive tumors are the most common breast cancers in postmenopausal women, and drug therapies, which block the production or effects of estrogen, are the mainstay of treatment in these patients. Due to their effectiveness in postmenopausal women, aromatase inhibitors (AIs) are the ...
What is the current status of trial NCT01954706?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2013-11. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01954706?
The interventions under investigation include: Usual Care (OTHER), Structured Exercise (OTHER).
Who is sponsoring clinical trial NCT01954706?
This trial is sponsored by Baltimore VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01954706's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia